-
1
المؤلفون: Peter Jürgen Goebell, Johanna Buncke, Katrin Schlack, Martin Boegemann, Andres J. Schrader, Michael Woike
المصدر: Transl Androl Urol
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, Discovery and development of mTOR inhibitors, medicine.disease, Interim analysis, Temsirolimus, Clinical research, Reproductive Medicine, Renal cell carcinoma, Internal medicine, Statistical significance, Cohort, medicine, Original Article on Management of Advanced Genitourinary Malignancies, Risk assessment, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e36c57ac75f7a1970f81751cd6d5c3eTest
https://doi.org/10.21037/tau-20-938Test -
2
المؤلفون: Tiffany Shaw, Hannah Lee, Robert A. Figlin
المصدر: ONCOLOGY. :306-310
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Cabozantinib, medicine.medical_treatment, Ipilimumab, chemistry.chemical_compound, Antineoplastic Agents, Immunological, Renal cell carcinoma, Internal medicine, Basic Helix-Loop-Helix Transcription Factors, medicine, Humans, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Randomized Controlled Trials as Topic, Everolimus, business.industry, MTOR Inhibitors, Immunotherapy, medicine.disease, Kidney Neoplasms, respiratory tract diseases, Axitinib, chemistry, Practice Guidelines as Topic, Nivolumab, business, Lenvatinib, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2384827fee72ba75eb3766c87f599354Test
https://doi.org/10.46883/onc.2021.3506.0306Test -
3
المؤلفون: Peter Trnka, Sean E. Kennedy
المصدر: Pediatric Nephrology. 36:1427-1438
مصطلحات موضوعية: Nephrology, Oncology, congenital, hereditary, and neonatal diseases and abnormalities, medicine.medical_specialty, 030232 urology & nephrology, Usually asymptomatic, 030204 cardiovascular system & hematology, 03 medical and health sciences, Tuberous sclerosis, 0302 clinical medicine, Renal cell carcinoma, hemic and lymphatic diseases, Internal medicine, medicine, neoplasms, PI3K/AKT/mTOR pathway, Kidney, business.industry, Treatment options, medicine.disease, Discovery and development of mTOR inhibitors, nervous system diseases, medicine.anatomical_structure, embryonic structures, Pediatrics, Perinatology and Child Health, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b9cf6eca4808f732ca49e5d23e8aea80Test
https://doi.org/10.1007/s00467-020-04775-1Test -
4
المؤلفون: Jorge A. Garcia, Pedro C. Barata, Moshe Chaim Ornstein
المصدر: Journal of Kidney Cancer and VHL
Journal of Kidney Cancer and VHL, Vol 4, Iss 2, Pp 10-18 (2017)مصطلحات موضوعية: Oncology, medicine.medical_specialty, mTOR inhibitors, medicine.drug_class, VEGF inhibitors, VEGF receptors, medicine.medical_treatment, Disease, Review Article, 030204 cardiovascular system & hematology, lcsh:RC870-923, lcsh:RC254-282, PD-1/PD-L1, Tyrosine-kinase inhibitor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, medicine, In patient, Receptor, sequential therapy, biology, business.industry, Advanced renal cell carcinoma, immunotherapy, mTOR inhibitors, PD-1/PD-L1, VEGF inhibitors, advanced renal cell carcinoma, Immunotherapy, medicine.disease, lcsh:Diseases of the genitourinary system. Urology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Vascular endothelial growth factor, chemistry, 030220 oncology & carcinogenesis, Immunology, biology.protein, immunotherapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d16b8b87b820d0bb015728b03bb6271Test
http://europepmc.org/articles/PMC5515898Test -
5
المؤلفون: Elżbieta Nowara, Joanna Huszno
المصدر: OncoReview. 6:143-148
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Everolimus, business.industry, medicine.disease, Discovery and development of mTOR inhibitors, Renal cell carcinoma, Internal medicine, Toxicity, medicine, Center (algebra and category theory), business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::367cac0bfd5b40d9c16c1d3ecaeb45afTest
https://doi.org/10.5604/20828691.1220904Test -
6
المؤلفون: Sitai Liang, Katarzyna Pietkun, Maciej Nowacki, Barbara Zegarska, Noor Y. Al-Obaidi, Wojciech Zegarski, Zhenze Zhao, Edward A. Medina, Samy L. Habib, Tomasz Drewa, Tomasz Kloskowski
المصدر: Journal of Cancer
مصطلحات موضوعية: mTOR inhibitors, congenital, hereditary, and neonatal diseases and abnormalities, Pathology, medicine.medical_specialty, Review, 03 medical and health sciences, Tuberous sclerosis, Epilepsy, 0302 clinical medicine, AML, Renal cell carcinoma, medicine, Subependymal zone, PI3K/AKT/mTOR pathway, TSC, business.industry, Genetic disorder, LAM, medicine.disease, nervous system diseases, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, SEGA, TSC1, TSC2, business, 030217 neurology & neurosurgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022670f0527a633d5bf7c9997d20daa2Test
https://doi.org/10.7150/jca.14747Test -
7
المؤلفون: Alessandro Conti, U. De Giorgi, Enrico Cortesi, Lorena Rossi, S Luca Burgio, Dino Amadori, Luciano Burattini, Matteo Santoni, Giovanni Muzzonigro, Rossana Berardi, Roberto Iacovelli, Stefano Cascinu
المصدر: British Journal of Cancer
مصطلحات موضوعية: Adult, Male, renal cell carcinoma, mTOR inhibitors, Cancer Research, medicine.medical_specialty, Pathology, Survival, Neutrophils, Colorectal cancer, Urology, Disease-Free Survival, tyrosine kinase inhibitor, neutrophil-to-lymphocyte ratio, Renal cell carcinoma, medicine, Humans, Everolimus, Lymphocyte Count, Lymphocytes, Neoplasm Metastasis, Neutrophil to lymphocyte ratio, Lung cancer, Carcinoma, Renal Cell, Aged, Aged, 80 and over, Sirolimus, targeted therapy, mtor inhibitors, everolimus, neutrophil-tolymphocyte ratio, business.industry, TOR Serine-Threonine Kinases, Middle Aged, medicine.disease, Kidney Neoplasms, Treatment Outcome, Oncology, Clinical Study, Female, Skin cancer, Liver cancer, business, Immunosuppressive Agents, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a063ad4216ed9b55fd7939f541fdd9Test
https://doi.org/10.1038/bjc.2013.522Test -
8
المؤلفون: Andrea Coinu, Sandro Barni, Fausto Petrelli
المصدر: Expert Review of Anticancer Therapy. 16:33-43
مصطلحات موضوعية: Risk, Oncology, medicine.medical_specialty, medicine.medical_treatment, 030232 urology & nephrology, Antineoplastic Agents, urologic and male genital diseases, Systemic therapy, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Renal cell carcinoma, Internal medicine, medicine, Humans, Pharmacology (medical), Molecular Targeted Therapy, Neoplasm Metastasis, Carcinoma, Renal Cell, Protein Kinase Inhibitors, business.industry, TOR Serine-Threonine Kinases, Prognosis, medicine.disease, Discovery and development of mTOR inhibitors, Kidney Neoplasms, Temsirolimus, Clinical trial, Clear cell renal cell carcinoma, Receptors, Vascular Endothelial Growth Factor, Drug Design, 030220 oncology & carcinogenesis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5adc6e1d02f7599745c5c47d3d301040Test
https://doi.org/10.1586/14737140.2016.1109454Test -
9
المؤلفون: Valentina Poletto, Marco Biggiogera, Camillo Porta, Germano Guerra, Francesco Moccia, Vittorio Rosti
المصدر: Critical reviews in oncology/hematology. 132
مصطلحات موضوعية: 0301 basic medicine, mTOR inhibitors, medicine.medical_specialty, Angiogenesis, Resistance, Endothelial colony forming cells, Angiogenesis Inhibitors, urologic and male genital diseases, Pathogenesis, 03 medical and health sciences, Renal cell carcinoma, Internal medicine, medicine, Neoplasm, Humans, Progenitor cell, Antiangiogenic agents, Hematology, Neovascularization, Pathologic, business.industry, TOR Serine-Threonine Kinases, medicine.disease, Kidney Neoplasms, 030104 developmental biology, Receptors, Vascular Endothelial Growth Factor, Oncology, Cancer research, Endothelium, Vascular, Signal transduction, business, Kidney cancer, Circulating endothelial cells, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::349cbba32689d5fa82295b8e7cc165e0Test
https://pubmed.ncbi.nlm.nih.gov/30447930Test -
10
المؤلفون: Faysal Dane, Hande Turna, Feyyaz Ozdemir, Esat Ulay, Ramazan Yildiz, Ozgur Ozyilkan, Ruchan Uslu, Alper Sevinc, Berna Oksuzoglu, Suayib Yalcin, Aziz Karaoglu
المساهمون: İç Hastalıkları, Ege Üniversitesi
المصدر: OncoTargets and therapy
مصطلحات موضوعية: Oncology, medicine.medical_specialty, mTOR inhibitors, Metastatic renal cell carcinoma, OncoTargets and Therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Interferon, Renal cell carcinoma, Internal medicine, Observational study, Medicine, Pharmacology (medical), In patient, 030212 general & internal medicine, Everolimus, Real-life setting, Adverse effect, Original Research, Treatment patterns, business.industry, medicine.disease, Vascular endothelial growth factor, chemistry, Tolerability, 030220 oncology & carcinogenesis, business, medicine.drug
وصف الملف: text/plain; application/pdf; text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757fc04f68f6fa57270e1d49fcd69eeeTest
http://hdl.handle.net/11655/14803Test